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ABSTRACT  
Sarcoplasmic reticulum (SR) Ca2+ cycling 
is governed by the cardiac ryanodine receptor 
(RyR2) and SR Ca2+-ATPase (SERCA2a). 
Abnormal SR Ca2+ cycling is thought to be the 
primary cause of Ca2+ alternans that can elicit 
ventricular arrhythmias and sudden cardiac 
arrest. Although alterations in either RyR2 or 
SERCA2a function are expected to affect SR 
Ca2+ cycling, whether and to what extent altered 
RyR2 or SERCA2a function affects Ca2+ 
alternans is unclear. Here we employed a gain-
of-function RyR2 variant (R4496C) and the 
phospholamban-knockout (PLB-KO) mouse 
model to assess the effect of genetically 
enhanced RyR2 or SERCA2a function on Ca2+ 
alternans. Confocal Ca2+ imaging revealed that 
RyR2-R4496C shortened SR Ca2+ release 
refractoriness and markedly suppressed rapid 
pacing-induced Ca2+ alternans. Interestingly, 
despite enhancing RyR2 function, intact RyR2-
R4496C hearts exhibited no detectable 
spontaneous SR Ca2+ release events during 
pacing. Unlike for RyR2, enhancing SERCA2a 
function by ablating PLB exerted a relatively 
minor effect on Ca2+ alternans in intact hearts 
expressing RyR2 wildtype or a loss-of-function 
RyR2 variant, E4872Q, that promotes Ca2+ 
alternans. Furthermore, partial SERCA2a 
inhibition with 3 µM 2,5-di-tert-
butylhydroquinone (tBHQ) also had little impact 
on Ca2+ alternans, while strong SERCA2a 
inhibition with 10 µM tBHQ markedly reduced 
the amplitude of Ca2+ transients and suppressed 
Ca2+ alternans in intact hearts. Our results 
demonstrate that enhanced RyR2 function 
suppresses Ca2+ alternans in the absence of 
spontaneous Ca2+ release and that RyR2, but not 
SERCA2a, is a key determinant of Ca2+ alternans 
in intact working hearts, making RyR2 an 
important therapeutic target for cardiac alternans. 
 
 
Intracellular Ca2+ alternans, one of the 
many forms of cardiac alternans, is a beat-to-beat 
alternation in the amplitude of the cytosolic Ca2+ 
transient. An increasing body of evidence 
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indicates that Ca2+ alternans can occur in the 
absence of other forms of cardiac alternans, 
supporting the notion that Ca2+ alternans plays a 
primary role in the genesis of cardiac alternans 
(1-11). Despite the well-recognized risk of 
cardiac alternans in ventricular fibrillation and 
sudden cardiac arrest (12-19), the molecular 
mechanisms underlying cardiac alternans are not 
well understood.  
Given its crucial role in cardiac alternans, 
understanding how Ca2+ alternans occurs would 
be key to the understanding of cardiac alternans. 
Over the past decades, major advances in the 
understanding of the mechanisms of Ca2+ 
alternans have been made. It has become clear 
that Ca2+ alternans results from altered SR Ca2+ 
cycling, which is governed by SR Ca2+ release 
and reuptake (9,11,20-25). 
Inhibiting RyR2 function either by 
tetracaine, intracellular acidification, or 
metabolic inhibition has been shown to prolong 
SR Ca2+ release refractoriness and promote Ca2+ 
alternans in isolated cardiomyocytes (26-30). On 
the other hand, increasing RyR2 function by 
caffeine shortens SR Ca2+ release refractoriness 
and suppresses Ca2+ alternans (31,32). These 
observations suggest that the activity of RyR2 is 
a major determinant of SR Ca2+ release 
refractoriness and Ca2+ alternans. Consistent with 
this view, we showed that genetically 
suppressing RyR2 function prolongs SR Ca2+ 
release refractoriness and promotes Ca2+ 
alternans in intact hearts (32). On the other hand, 
shortened refractoriness of SR Ca2+ release as a 
result of CASQ2 ablation suppresses Ca2+ 
alternans in intact hearts (33). These findings 
support a general notion that suppressing the 
activity of RyR2 prolongs the refractoriness of 
SR Ca2+ release and promotes Ca2+ alternans, 
whereas, enhancing RyR2 activity shortens the 
refractoriness of SR Ca2+ release and suppresses 
Ca2+ alternans (10,31,32,34,35). However and 
contrary to this expectation, enhanced RyR2 
function as a result of some genetic mutations or 
abnormal redox modifications has been shown to 
promote Ca2+ alternans in isolated 
cardiomyocytes (36-38). For instance, the 
CPVT-causing, gain-of-function (GOF) RyR2 
mutation R4496C has been shown to reduce the 
refractoriness of SR Ca2+ release in the mouse 
trabecular muscle (39). However, the same GOF 
RyR2 R4496C mutation was found to promote 
Ca2+ alternans in isolated cardiac cells (40). 
Therefore, it remains unclear whether enhanced 
RyR2 function suppresses or promotes Ca2+ 
alternans. 
These seemingly conflicting observations 
also raise an important question of why 
enhanced RyR2 activity and shortened 
refractoriness of SR Ca2+ release are unable to 
suppress Ca2+ alternans in the isolated RyR2 
R4496C mutant cells. One possible explanation 
is that enhanced RyR2 activity would increase 
the propensity for spontaneous Ca2+ release 
(SCR), such as Ca2+ sparks and Ca2+ waves, 
which in turn would promote Ca2+ alternans 
(25,28,38,41-46). Hence, it would be of interest 
and importance to determine whether enhanced 
RyR2 function promotes Ca2+ alternans in intact 
working hearts that exhibit little or no SCR 
during stimulation (47).  
SR Ca2+ reuptake, another important aspect 
of SR Ca2+ cycling, is also believed to play an 
important role in Ca2+ alternans. Overexpression 
of the cardiac sarco/endoplasmic reticulum Ca2+ 
ATPase (SERCA2a) suppresses Ca2+ alternans, 
whereas, reducing SERCA2a expression or 
activity promotes Ca2+ alternans (5,9,48-51). 
However, severely reducing the activity of 
SERCA2a may suppress, rather than promote, 
Ca2+ alternans, probably due to reduced SR Ca2+ 
content (25,46,52). Interestingly, atrial 
overexpression of SERCA2a has little effect on 
cardiac alternans (53). Hence, the effect of 
altered SERCA2a activity on Ca2+ alternans is 
complex and variable, and the relative 
contribution of altered RyR2 and SERCA2a 
activity to the genesis of Ca2+ alternans is also 
unclear. 
In the present study, we carried out laser-
scanning confocal Ca2+ imaging of 
cardiomyocytes in intact WT and RyR2 mutant 
hearts that exhibited little spontaneous Ca2+ 
release. We assessed the impact of the GOF 
RyR2 R4496C mutation on SR Ca2+ release 
refractoriness and Ca2+ alternans, and the effects 
of inhibiting or enhancing SERCA2a activity on 
Ca2+ alternans in intact hearts. We demonstrate 
that genetically enhancing RyR2 function 
shortens Ca2+ release refractoriness and 
suppresses Ca2+ alternans in intact hearts without 
producing spontaneous SR Ca2+ release. We also 
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demonstrate that genetically enhancing 
SERCA2a function by PLB ablation had a 
relatively minor impact on Ca2+ alternans in 
intact hearts. Furthermore, we found that modest 
inhibition of SERCA2a function also had little 
impact on Ca2+ alternans in intact hearts. 
Collectively, our data demonstrate that the 
activity of RyR2, but not SERCA2a, is a major 
determinant of Ca2+ alternans in intact working 
mouse hearts.    
 
Results 
Genetically enhancing RyR2 function reduces 
the refractoriness of SR Ca2+ release in intact 
hearts 
We have recently shown that genetically 
suppressing RyR2 function lengthens the 
refractoriness of SR Ca2+ release in intact hearts 
(32). It is unclear whether genetically enhancing 
RyR2 function would shorten the refractoriness 
of SR Ca2+ release in intact hearts. To address 
this question, we employed the RyR2 R4496C 
mutation, a CPVT-linked gain-of-function 
(GOF) RyR2 mutation that has been shown to 
significantly enhance the sensitivity of the 
channel to Ca2+ activation (54-56). We 
determined the refractoriness of SR Ca2+ release 
in isolated Langendorff-perfused intact RyR2 
WT and heterozygous RyR2 R4496C mutant 
hearts using the S1S2 stimulation protocol (10). 
As shown in Fig.1, the amplitude of Ca2+ 
transients in both the WT and RyR2 R4496C 
hearts decreased when the S1S2 interval was 
progressively reduced (from 200 ms to 40 ms) 
(Fig. 1A, B). However, the WT and RyR2 
R4496C hearts showed significantly different 
relationships between the Ca2+ transient 
amplitude and S1S2 interval (Fig. 1C) (P<0.05). 
The Ca2+ transient amplitude of the RyR2 
R4496C hearts recovered faster than that of the 
WT hearts at S1S2 intervals between 75-160 ms. 
Therefore, these data demonstrate that, opposite 
to the effect of suppressing RyR2 function (32), 
genetically enhancing RyR2 function shortens 
the refractoriness of SR Ca2+ release.  
 
Enhancing RyR2 function markedly suppresses 
rapid-stimulation induced Ca2+ alternans in 
intact hearts 
Prolonged refractoriness of SR Ca2+ 
release is known to promote Ca2+ alternans 
(10,31,32,34,35). Thus, a shortened 
refractoriness of SR Ca2+ release as a result of 
the RyR2 R4496C mutation would be expected 
to suppress Ca2+ alternans. To test this 
possibility, we determined the propensity for  
 
 
Ca2+ alternans in isolated Langendorff-perfused 
intact RyR2 WT and heterozygous RyR2 
R4496C mutant hearts. As shown in Fig. 2, 
RyR2 WT hearts exhibited significant beat-to-
beat alternations in the amplitude of Ca2+ 
transients at the stimulation frequency of 12 Hz 
(Fig. 2A). On the other hand, RyR2 R4496C 
mutant hearts displayed little or no beat-to-beat 
variations in the amplitude of Ca2+ transients at 
the same stimulation frequency (12 Hz) (Fig. 
2B).  
The frequency-dependence of Ca2+ 
alternans in intact WT and RyR2 R4496C hearts 
is shown in Fig. 2C, D. Substantial Ca2+ 
alternans could be readily detected in RyR2 WT 
hearts stimulated at 10-11 Hz, whereas higher 
stimulation frequencies (13-14 Hz) were 
required to induce considerable Ca2+ alternans in 
RyR2 R4496C mutant hearts (Fig. 2C,D). 
Furthermore, RyR2 R4496C hearts showed 
significantly lower alternans ratio and alternans 
duration at each stimulation frequency between 
10-14 Hz (Fig.2C, D) (P<0.01). Taken together, 
these data indicate that, opposite to the effect of 
suppressing RyR2 function (32), genetically 
enhancing RyR2 function markedly suppresses 
rapid stimulation-induced Ca2+ alternans in intact 
hearts.  
 
No spontaneous Ca2+ sparks or Ca2+ waves were 
detected in intact RyR2-R4496C mutant hearts 
during Ca2+ alternans  
It has been shown that the RyR2 R4496C 
mutation increases the propensity for 
spontaneous Ca2+ release (SCR, Ca2+ sparks and 
Ca2+ waves) (40,55,57). It is thought that SCR 
necessitates and facilitates the occurrence of 
Ca2+ alternans (25,28,38,41-46). Hence, it is of 
interest to determine whether SCR is involved in 
the occurrence of Ca2+ alternans in intact 
working RyR2 R4496C mutant hearts. Figure 3 
shows Ca2+ transients in intact RyR2-R4496C 
hearts continuously stimulated with increasing 
frequencies from 6 to 14 Hz (Fig. 3 and Suppl. 
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Fig. 1). Surprisingly, despite the enhanced RyR2 
function, intact working RyR2 R4496C mutant 
hearts exhibited no detectable spontaneous Ca2+ 
sparks or Ca2+ waves before or after the 
occurrence of Ca2+ alternans. The continued 
high-frequency stimulations likely override SCR 
in the intact working RyR2-R4496C hearts. 
Consistent with this view, spontaneous Ca2+ 
waves were readily observed in intact RyR2-
R4496C mutant hearts, but not in WT hearts, 
after the cessation of pacing in the presence of 
high adrenergic stress (1µM epinephrine plus 
0.6 mM caffeine) (Fig. 4). It is important to note 
that the same condition (1µM epinephrine plus 
0.6 mM caffeine) also induced VTs in intact 
working RyR2-R4496C hearts as reported 
previously (47). Hence, the Ca2+ alternans 
observed in rapidly-stimulated intact RyR2 
R4496C mutant hearts are unrelated to 
spontaneous Ca2+ sparks or Ca2+ waves.  
 
Enhancing SERCA2a function by 
phospholamban knock-out has relatively small 
impact on Ca2+ alternans in intact RyR2 WT or 
E4872Q mutant hearts 
It is clear that modulating the activity of 
RyR2 has a major impact on Ca2+ alternans (26-
30,32). However, the relative impact of 
modulating the activity of SERCA2a, another 
key component of SR Ca2+ cycling, on Ca2+ 
alternans is unclear. To this end, we assessed the 
impact of phospholamban knock-out (PLBKO) 
on Ca2+ alternans in intact RyR2 WT or E4872Q 
mutant hearts. The RyR2 E4872Q mutation has 
been shown to suppress Ca2+ activation of RyR2 
and the occurrence of spontaneous Ca2+ waves 
(32,58,59). As expected, PLBKO markedly 
increased the amplitude of Ca2+ transients and 
reduced the transient decay time (T50) as 
compared with WT hearts (Suppl. Fig. 2), 
consistent with its stimulatory action on 
SERCA2a and SR Ca2+ reuptake (60). 
Surprisingly, PLBKO did not significantly alter 
the average alternans ratios at stimulation 
frequencies from 5 to 14 Hz (Fig. 5). PLBKO 
significantly reduced the average alternans 
durations only at stimulation frequencies of 10, 
11 and 12 Hz (Fig. 5D). Thus, Comparing to 
enhancing RyR2 function, enhancing SERCA2a 
function as a result of PLBKO has relatively 
small impact on Ca2+ alternans in intact WT 
hearts. 
We also assessed whether PLBKO could 
rescue the enhanced Ca2+ alternans in RyR2 
E4872Q mutant hearts with suppressed RyR2 
function. Similar to those observed in RyR2 WT 
hearts (Suppl. Fig. 2), PLBKO significantly 
increased the amplitude of Ca2+ transients and 
reduced the transient decay time (T50) in intact 
RyR2 E4872Q mutant hearts (Suppl. Fig. 3). 
PLBKO also significantly increased the SR Ca2+ 
content in WT ventricular myocytes, as 
expected, and dramatically increased the SR 
Ca2+ content in RyR2 E4872Q mutant cells 
(Suppl. Fig. 4). However, PLBKO had no 
significant impact on the average alternans ratio 
of RyR2 E4872Q hearts at stimulation 
frequencies from 5 to 14 Hz (Fig. 6). PLBKO 
significantly reduced the average alternans 
duration only at the stimulation frequency of 9 
Hz (Fig. 6D). Thus, enhancing SERCA2a 
function by PLBKO does not suppress the 
enhanced Ca2+ alternans in RyR2 E4872Q 
mutant hearts. These observations also suggest 
that, although the SR Ca2+ content is an 
important regulator of SR Ca2+ handling, it does 
not seem to play a critical role in Ca2+ alternans.  
 
Effect of SERCA2a inhibition on Ca2+ 
alternans in intact hearts 
We next assessed the effect of 2, 5-di-tert-
butylhydroquinone (tBHQ), an inhibitor of 
SERCA2a, on Ca2+ alternans in intact RyR2 WT 
and E4872Q mutant hearts. As expected, tBHQ 
at 3 and 10 µM significantly reduced the 
amplitude of Ca2+ transients. It also prolonged 
the transient decay time (T50) in RyR2 WT 
hearts by 13% (at 3 µM) and 16% (at 10 µM) 
(Suppl. Fig. 5). This is consistent with the 
inhibitory action of tBHQ on SERCA2a and SR 
Ca2+ reuptake. However, despite its significant 
impact on SERCA2a, tBHQ at 3 µM did not 
significantly affect the average alternans ratio or 
duration in intact RyR2 WT hearts stimulated at 
a wide range of frequencies (from 5 to 14 Hz) 
(Fig. 7). Surprisingly, tBHQ at 10 µM markedly 
reduced both the average alternans ratio and 
duration in intact RyR2 WT hearts at stimulation 
frequencies of 11 – 14 Hz (Fig. 7). These data 
indicate that, depending on the extent of 
SERCA2a inhibition, reducing SERCA2a 
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function either has a relatively minor impact on 
Ca2+ alternans or can lead to marked suppression 
of Ca2+ alternans. 
We also assessed the impact of tBHQ on 
Ca2+ alternans in intact RyR2 E4872Q mutant 
hearts (32,58). Similar to those observed in 
RyR2 WT hearts, tBHQ at 3 and 10 µM 
significantly reduced the amplitude of Ca2+ 
transients. It also prolonged the decay time 
(T50) of Ca2+ transients by 8% (at 3 µM) and 
16% (at 10 µM) (Suppl. Fig. 6). As with intact 
WT hearts, tBHQ at 10 µM also significantly 
reduced the average alternans ratio and duration 
in intact RyR2 E4872Q mutant hearts (Fig. 8). 
On the other hand, tBHQ at 3 µM had minor 
effect on the average alternans ratio or duration 
in intact E4872Q hearts (Fig. 8). Collectively, 
these data indicate that compared with RyR2, 
SERCA2a plays a relatively minor role in Ca2+ 
alternans in intact hearts.  
 
Discussion 
Beat-to-beat alternations in the amplitude 
of the cytosolic Ca2+ transient (Ca2+ alternans) 
are thought to be the primary cause of cardiac 
alternans (1-11), which is a major risk factor for 
ventricular arrhythmias and sudden cardiac 
arrest (12-19). Despite its important role in 
arrhythmogenesis, the molecular mechanism 
underlying Ca2+ alternans remains undefined. An 
increased body of evidence suggests that Ca2+ 
alternans results from abnormal SR Ca2+ cycling 
(9,11,21-25). Since SR Ca2+ cycling is governed 
by SR Ca2+ release via RyR2 and SR Ca2+ 
reuptake by SERCA2a (20), altered RyR2 or 
SERCA2a function would be expected to affect 
SR Ca2+ cycling, thus leading to Ca2+ alternans. 
However, how changes in the activity of RyR2 
or SERCA2a affect Ca2+ alternans is unclear. To 
address this question, here we determined the 
impact of genetically or pharmacologically 
enhancing or suppressing RyR2 or SERCA2a 
function on Ca2+ alternans in intact working 
hearts. We found that altering RyR2 function, 
but not SERCA2a function, has a major impact 
on Ca2+ alternans. These findings shed new 
insights into the molecular mechanism of Ca2+ 
alternans and have important therapeutic 
implications to cardiac alternans.  
Recent studies have consistently shown 
that suppressing the function of RyR2 prolongs 
the refractoriness of SR Ca2+ release and 
promotes Ca2+ alternans (26-30,32). However, 
the impact of enhanced RyR2 function on Ca2+ 
alternans is unclear. On the one hand, enhancing 
RyR2 function would increase spontaneous Ca2+ 
release (Ca2+ sparks/Ca2+ waves), which would 
promote Ca2+ alternans (25,28,38,41-46). On the 
other hand, enhancing RyR2 function would 
shorten SR Ca2+ release refractoriness, which 
would suppress Ca2+ alternans 
(10,31,32,34,35,39). To ascertain these 
seemingly paradoxical effects of enhanced RyR2 
function on Ca2+ alternans, we determined the 
impact of a disease-causing RyR2 mutation 
(R4496C) with enhanced channel activity on 
Ca2+ alternans in the setting of intact working 
hearts. We found that, despite the enhanced 
RyR2 activity, intact working RyR2 R4496C 
mutant hearts displayed little or no spontaneous 
Ca2+ sparks or waves during electrical 
stimulation, similar to that reported previously 
(47). This is also consistent with the observation 
that increased heart rate alone (as in 
programmed electrical stimulation) can rarely 
trigger VTs in patients with CPVT (61). In 
contrast, accelerating heart rate (in the absence 
of excessive adrenergic stress) suppresses 
spontaneous Ca2+ release and prevents VTs in 
both CPVT animal models and patients (62). 
Furthermore, we found that, in the absence of 
Ca2+ sparks/waves, enhancing RyR2 function 
shortens SR Ca2+ release refractoriness and 
suppresses Ca2+ alternans. Hence, opposite to 
depressed RyR2 function, which promotes Ca2+ 
release refractoriness and Ca2+ alternans and 
suppresses stress-provoked CPVT, enhanced 
RyR2 function protects against Ca2+ alternans, 
but promotes CPVT. These observations suggest 
that the mechanisms underlying stress-provoked 
CPVT and Ca2+ alternans are different. It is of 
interest to not that, opposite to our findings, 
enhanced RyR2 function has been shown to 
promote Ca2+ alternans in isolated 
cardiomyocytes where spontaneous Ca2+ release 
is present (36,38,40). These observations 
suggest that the presence or absence of 
spontaneous SR Ca2+ release may influence 
whether enhanced RyR2 function will promote 
or suppress Ca2+ alternans, and that the nature 
and mechanisms of Ca2+ alternans with or 
without spontaneous SR Ca2+ release may be 
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different. Further studies are needed to fully 
understand the role of spontaneous Ca2+ release 
in the genesis of Ca2+ alternans. 
The role of SERCA2a in Ca2+ alternans is 
complex. On the one hand, reduced SERCA2a 
function would decrease SR Ca2+ content and 
thus SR Ca2+ release, which would suppress Ca2+ 
alternans. On the other hand, reduced SERCA2a 
function would prolong Ca2+ transient decay and 
elevate cytosolic Ca2+ concentration, which 
would promote Ca2+ alternans (25,31,46,52). 
Similarly, enhanced SERCA2a function would 
increase SR Ca2+ content and thus SR Ca2+ 
release, which would promote Ca2+ alternans. In 
contrast, enhanced SERCA2a function would 
hasten Ca2+ transient decay and reduce cytosolic 
Ca2+ concentration, which would suppress Ca2+ 
alternans (25,31,46,52). Thus, changes in the 
activity of SERCA2a would promote or suppress 
Ca2+ alternans, depending on the relative 
changes in the cytosolic Ca2+ concentration and 
the SR Ca2+ content. Furthermore, since the 
activity of SERCA2a oppositely affects the 
cytosolic Ca2+ concentration and SR Ca2+ 
content, changes in the SERCA2a activity would 
be expected to have only a minor impact on Ca2+ 
alternans due to the resultant opposite changes in 
the cytosolic Ca2+ concentration and SR Ca2+ 
content. Indeed, consistent with this view, we 
found that genetically enhancing the SERCA2a 
function by PLBKO significantly increased the 
amplitude of SR Ca2+ release, which would 
promote Ca2+ alternans, but decreased the decay 
time of Ca2+ transients, which would suppress 
Ca2+ alternans. As a result of these opposing 
effects, PLBKO did not markedly alter Ca2+ 
alternans in intact WT hearts. We also found that 
PLBKO did not rescue the enhanced Ca2+ 
alternans in intact RyR2 E4872Q mutant hearts.  
We also investigated the impact of 
reduced SERCA2a function on Ca2+ alternans. 
Partially reducing SERCA2a activity using a 
low concentration of tBHQ (3 µM) reduced the 
amplitude of SR Ca2+ release, which would 
suppress Ca2+ alternans, but increased the decay 
time of Ca2+ transients, which would promote 
Ca2+ alternans. As a result, these opposing 
actions of tBHQ in the amplitude and decay time 
of Ca2+ transients led to no marked alteration in 
Ca2+ alternans in intact WT hearts. We also 
found that tBHQ (3 µM) had no major impact on 
the enhanced Ca2+ alternans in intact RyR2 
E4872Q mutant hearts. Interestingly, further 
inhibition of SERCA2a activity using a higher 
concentration of tBHQ (10 µM) significantly 
suppressed Ca2+ alternans in intact WT or 
E4872Q mutant hearts. This suppression on Ca2+ 
alternans likely resulted from the stronger effect 
of 10 µM tBHQ on the reduction in SR Ca2+ 
content, as a result of stronger inhibition of 
SERCA2a activity, than on the increase in Ca2+ 
transient decay. Taken together, our findings 
indicate that moderate changes in the SERCA2a 
function have a relatively minor impact on Ca2+ 
alternans in intact working hearts. However, it is 
important to note that altered SERCA2a function 
also affects the propensity for spontaneous Ca2+ 
release. Thus, changes in SERCA2a function 
may play an important role in Ca2+ alternans in 
the setting of disease hearts where spontaneous 
Ca2+ release is enhanced. 
Although genetically engineered mouse 
models harboring a RyR2 GOF or loss-of-
function mutation or a PLB deletion allow us to 
determine the effect of specifically reducing or 
enhancing RyR2 or SERCA2a function on Ca2+ 
alternans, whether our findings from these 
mouse hearts could be translated into the human 
hearts is unclear. It is known that intracellular 
Ca2+ handling and electrophysiological 
properties of the mouse hearts are substantially 
different from those of the human hearts. Hence, 
the significance and relative contribution of 
RyR2 and SERCA2a function on Ca2+ alternans 
in human hearts has yet to be determined.  
In summary, the present study 
demonstrates for the first time that genetically 
enhancing RyR2 function shortens SR Ca2+ 
release refractoriness and protects against Ca2+ 
alternans in intact working hearts. On the other 
hand, enhancing or suppressing SERCA2a 
function have a relatively minor impact on Ca2+ 
alternans in intact working hearts. These 
findings indicate that the activity of RyR2, but 
not SERCA2a, is a major determinant of Ca2+ 
alternans. Thus, RyR2 represents a promising 
therapeutic target for cardiac alternans. 
 
Experimental procedures 
Animal studies — All animal studies were 
approved by the Institutional Animal Care and 
Use Committee at the University of Calgary and 
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performed in accordance with NIH guidelines. 
The phospholamban (PLB) knockout, RyR2-
R4496C, and RyR2-E4872Q knock-in mutant 
mice were generated as previously described 
(56,58,60). The RyR2-E4872Q mutant mice 
were cross-bred with the phospholamban (PLB) 
knockout mice (PLN-KO) to produce a PLB 
deficient mouse line expressing the 
heterozygous RyR2-E4872Q+/- mutation (PLB-
KO/EQ+/-). Adult RyR2-R4496C+/-, RyR2-
E4872Q+/-, PLB-KO, and PLB-KO/EQ+/- mutant 
and wildtype control mice (8-12 weeks) were 
used for all experiments. 
 
Determination of refractoriness of SR Ca2+ 
release — The refractoriness of voltage-induced 
release of Ca2+ from the sarcoplasmic reticulum 
(SR) was determined by using the S1S2 
stimulation protocol as described previously 
with some modifications (10,32). Briefly, Ca2+ 
transients in Rhod-2 AM loaded hearts were first 
induced at 5 Hz for 5 seconds (S1), followed by 
a single S2 stimulation at a specific interval. The 
hearts were repeatedly stimulated by a series of 
S1S2 protocols with progressively decreased 
S1S2 intervals (from 200 to 40 ms). Ca2+ 
transients before and after S2 stimulation were 
continuously recorded by using the Nikon‐ A1R 
confocal microscope in the line-scan mode. 
 
Laser scanning confocal Ca2+ imaging of intact 
hearts — WT and mutant mice were sacrificed 
by cervical dislocation. Their hearts were 
quickly removed and loaded with 4.4 µM 
Rhod‐ 2 AM (Biotium, Inc. Hayward, CA) in 
oxygenated Tyrode’s buffer (118 mM NaCl, 5.4 
mM KCl, 25 mM NaHCO3, 1 mM MgCl2, 0.42 
mM NaH2PO4, 11.1 mM glucose, 10 mM 
taurine, 5 mM creatine, and 1.8 mM CaCl2, pH 
7.4) via retrograde Langendorff perfusion 
system at 25°C for 45 minutes (47,63). The 
Langendorff-perfused hearts were placed in a 
recording chamber mounted onto the Nikon 
A1R microscope for in situ confocal imaging 
(line-scan) of Ca2+ signals from epicardial 
ventricular myocytes. The temperature of the 
heart was kept at 35C throughout the 
experiment with 5 µM blebbistatin (Toronto 
Research Chemicals, Toronto, ON) to prevent 
motion artifact. The pixel size of the resulting 
line-scan images ranged between 1.8 and 2 ms in 
the temporal dimension and between 0.1 to 0.4 
microns in the spatial dimension. Ca2+ alternans 
in the WT and mutant hearts in the absence or 
presence of 2,5-di-tert-butylhydroquinone 
(tBHQ) (3 µM or 10 µM) was induced by rapid 
electrical stimulation at increasing frequencies 
(5-14 Hz, 6 V).  
 
Image and signal processing — The signal and 
image processing methods were implemented 
using MATLAB (The Mathworks Inc., Boston, 
MA) as previously described (32). Briefly, line-
scan fluorescence images were filtered 
according to the noise level estimated by the 
median absolute deviation of the pixel 
intensities. Individual cells in the images were 
manually marked and the average fluorescence 
in each cell obtained for further analysis. A 
wavelet peak detection algorithm was used in 
order to detect individual calcium release events 
in the average fluorescence signals. For each 
event detected in each cell, we determined the 
peak amplitude (local min-max difference) and 
the alternans ratio (relative amplitude difference 
between consecutive peaks). The presence of 
alternans periods was established when six 
consecutive peaks presented an alternans ratio 
above 0.05. Alternans duration was defined as 
the percentage of alternans periods over the total 
line-scan duration. Average magnitudes were 
obtained by taking the mean over each line-scan.  
 
Statistical Analysis — GraphPad Prism 6.0 was 
used for statistical analyses. All values shown 
are mean ± SD unless indicated otherwise. To 
test for differences between groups, we used 
Student's t test (2-tailed) or one or two-Way 
ANOVA with a Dunnett’s or Bonferronis’s post 
hoc test when appropriate. A P value <0.05 was 
considered to be statistically significant. 
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FOOTNOTES 
 
The abbreviations used are: RyR2, cardiac ryanodine receptor; CPVT, catecholaminergic polymorphic 
ventricular tachycardia; DAD, delayed afterdepolarization; PLB, phospholamban; SR, sarcoplasmic 
reticulum; SCR, spontaneous Ca2+ release; SERCA2a, cardiac sarco/endoplasmic reticulum Ca2+-ATPase; 
AP, action potential; tBHQ, 2,5-di-tert-butylhydroquinone; CASQ2, cardiac calsequestrin; LTCC, L-type 
Ca2+ Channel; Na+/Ca2+, sodium/calcium exchange; GOF, gain-of-function; LOF, loss-of-function. 
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FIGURES 
 
 
 
Figure 1. RyR2-R4496C mutation shortens the refractoriness of SR Ca2+ release. Langendorff-
perfused intact RyR2 WT (A) and R4496C mutant (B) hearts were loaded with Rhod-2 AM. Hearts were 
first stimulated at 5 Hz for 30 beats (S1), followed by a single S2 stimulation. A series of S1S2 
stimulations were repeatedly applied with progressively reduced S1S2 intervals from 200 ms to 40 ms. 
Ca2+ transients were recorded using line-scanning confocal imaging. (C) The relationship between A2/A1 
ratio of the Ca2+ transient amplitude and S1S2 interval is shown. Data shown are mean ± SD (n = 5 hearts 
for WT, n = 7 hearts for R4496C) (*P<0.05).  
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Figure 2. Ca2+ transient alternans in intact RyR2 WT and RyR2-R4496C hearts. Langendorff-
perfused intact RyR2 WT (A) and R4496C mutant (B) hearts were loaded with Rhod-2 AM. Ca2+ 
transients in intact Rhod-2 AM loaded RyR2 WT and RyR2-R4496C mutant hearts were elicited by 
pacing at different frequencies (5-16 Hz), and recorded using line-scanning confocal imaging. Cell 
boundaries were indicated by short bars to the left. The ∆F/Fo traces depict the average fluorescence 
signal of the scan area. Alternans ratio for each cell that displayed alternans in the scan area and alternans 
duration for each cell in the same scan area were determined and averaged per cell to yield the average 
alternans ratio (C) and average alternans duration (D). Alternans ratio is defined as the ratio of the 
difference in amplitude between the large and small Ca2+ transients over the amplitude of the large Ca2+ 
transient. Alternans duration is defined as the percentage of time in alternans over the 10-s scanning 
period. Data shown are mean ± SD (n = 6 hearts for WT at stimulation frequencies 5-14 Hz, and n=3 
hearts for WT at 15-16 Hz; n = 11 hearts for R4496C at stimulation frequencies 5-14 Hz, and n = 6 hearts 
for RC for 15-16 Hz). Two-Way ANOVA with a Bonferroni's post hoc test (**P<0.01). For the analysis 
of alternans ratios, the F statistics for the Row factor (pacing frequency) is F=112.763, p<0.01; the 
column factor (genotypes) F=282.836, P<0.01; interaction between the Column and Row Factors 
F=26.7164; P<0.01. For the analysis of alternans durations, the F statistics for the Row factor (pacing 
frequency) is F=59.165, p<0.01; the column factor (genotypes) F=83.86, P<0.01; interaction between the 
Column and Row Factors F=11.127; P<0.01. 
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Figure 3. Intact working RyR2-R4496C hearts exhibit no detectable spontaneous Ca2+ release 
events during pacing. Intact Rhod-2 AM loaded R4496C mutant hearts were stimulated at increasing 
frequencies (6-14 Hz), and recorded using line-scanning confocal imaging. (A) Ca2+ transients at 6 Hz. 
(B) Ca2+ transients at 10 Hz. (C) Ca2+ transients at 14 Hz. There were no spontaneous Ca2+ sparks or Ca2+ 
waves detected during pacing.  
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Figure 4. Intact working RyR2-R4496C hearts display spontaneous Ca2+ waves after cessation of 
stimulation. Intact Rhod-2 AM loaded RyR2 WT (A) and R4496C mutant (B) hearts were stimulated at 6 
Hz (indicated by a red line) and recorded using line-scanning confocal imaging during stimulation and 
after the cessation of stimulation. (C) Percentage (%) of cells in intact WT and R4496C hearts that 
displayed spontaneous Ca2+ waves (indicated by red triangles). Spontaneous sinus rhythm is indicated by 
a green line or green triangles. Data shown are mean ± SD (n=5 hearts for RyR2 WT; n=5 hearts for 
R4496C (**P<0.01). 
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Figure 5. Ca2+ transient alternans in intact WT and PLB-KO hearts. Langendorff-perfused intact 
RyR2 WT (A) and PLB-KO (B) hearts were loaded with Rhod-2 AM. Ca2+ transients were elicited by 
pacing at different frequencies (5-14 Hz), and recorded using line-scanning confocal imaging. Cell 
boundaries were indicated by short bars to the left. The ∆F/Fo traces depict the average fluorescence 
signal of the scan area. The average alternans ratio (C) and average alternans duration (D) in intact RyR2 
WT and PLB-KO hearts at different stimulation frequencies are shown. Data shown are mean ± SD (n = 6 
hearts for WT, n = 9 hearts for PLB-KO). Two-Way ANOVA with a Bonferroni's post hoc test 
(*P<0.05). For the analysis of alternans ratios, the F statistics for the Row factor (pacing frequency) is 
F=113.179, p<0.01; the column factor (genotypes) F=2.859, P=0.0932; interaction between the Column 
and Row Factors F=1.589; P=0.1249. For the analysis of alternans durations, the F statistics for the Row 
factor (pacing frequency) is F=124.8, p<0.01; the column factor (genotypes) F=18.94, P<0.01; interaction 
between the Column and Row Factors F=1.65; P=0.1215. 
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Figure 6. Ca2+ alternans in intact RyR2-E4872Q hearts with or without PLB-KO. Langendorff-
perfused intact RyR2-E4872Q (A) and PLB-KO/RyR2-E4872Q+/- (PLB-KO/EQ) (B) hearts were loaded 
with Rhod-2 AM. Ca2+ transients were elicited by pacing at different frequencies (5-14 Hz), and recorded 
using line-scanning confocal imaging. Cell boundaries were indicated by short bars to the left. The ∆F/Fo 
traces depict the average fluorescence signal of the scan area. The average alternans ratio (C) and average 
alternans duration (D) intact RyR2-E4872Q and PLB-KO/EQ at different stimulation frequencies are 
shown. Data shown are mean ± SD (n = 5 hearts for E4872Q, n = 8 hearts for PLB-KO/EQ). Two-Way 
ANOVA with a Bonferroni's post hoc test (*P<0.05). For the analysis of alternans ratios, the F statistics 
for the Row factor (pacing frequency) is F=54.76, P<0.01; the column factor (genotypes) F=13.26, 
P<0.01; interaction between the Column and Row Factors F=1.276; P=0.257. For the analysis of alternans 
durations, the F statistics for the Row factor (pacing frequency) is F=38.66, P<0.01; the column factor 
(genotypes) F=13.874, P<0.01; interaction between the Column and Row Factors F=0.726; P=0.6834. 
 
 
 by guest on N
ovem
ber 28, 2018
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
 23 
 
 
 
Figure 7. Effect of tBHQ on Ca2+ alternans ratio and duration in intact RyR2 WT hearts. 
Langendorff-perfused intact RyR2 WT hearts were loaded with Rhod-2 AM. Ca2+ transients were elicited 
by pacing at different frequencies (5-14 Hz), and recorded using line-scanning confocal imaging before 
(A) and after the treatment of 3 µM (B) or 10 µM (C) tBHQ. Cell boundaries were indicated by short bars 
to the left. The ∆F/Fo traces depict the average fluorescence signal of the scan area. The average alternans 
ratio (D) and average alternans duration (E) at different stimulation frequencies are shown. Data shown 
are mean ± SD (n = 11 hearts before tBHQ treatment, n=8 hearts after 3 µM tBHQ, n = 6 hearts after 10 
µM tBHQ). Two-Way ANOVA with a Dunnett's post hoc test (**P<0.01). For the analysis of alternans 
ratios, the F statistics for the Row factor (pacing frequency) is F=153.906, P<0.01; the column factor 
(tBHQ treatment) F=108.024, P<0.01; interaction between the Column and Row Factors F=17.8275; 
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P<0.01. For the analysis of alternans durations, the F statistics for the Row factor (pacing frequency) is 
F=84.08, P<0.01; the column factor (tBHQ treatment) F=86.24, P<0.01; interaction between the Column 
and Row Factors F=7.386; P<0.01. 
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Figure 8. Effect of tBHQ on Ca2+ alternans ratio and duration in intact RyR2-E4872Q hearts. 
Langendorff-perfused intact RyR2-E4872Q hearts were loaded with Rhod-2 AM. Ca2+ transients were 
elicited by pacing at different frequencies (5-14 Hz), and recorded using line-scanning confocal imaging 
before (A) and after the treatment of 3 µM (B) or 10 µM (C) tBHQ. Cell boundaries were indicated by 
short bars to the left. The ∆F/Fo traces depict the average fluorescence signal of the scan area. The 
average alternans ratio (D) and average alternans duration (E) at different stimulation frequencies are 
shown. Data shown are mean ± SD (n = 5 hearts each for control, 3 µM, and 10 µM tBHQ groups. Two-
Way ANOVA with a Dunnett's post hoc test (*P<0.05, **P<0.01). For the analysis of alternans ratios, the 
F statistics for the Row factor (pacing frequency) is F=32.41, P<0.01; the column factor (tBHQ treatment) 
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F=107.4, P<0.01; interaction between the Column and Row Factors F=6.527; P<0.01. For the analysis of 
alternans durations, the F statistics for the Row factor (pacing frequency) is F=28.754, P<0.01; the 
column factor (tBHQ treatment) F=35.61, P<0.01; interaction between the Column and Row Factors 
F=1.538; P=0.1035. 
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